| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |